Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (78 ms)
| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.101/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101 |
| Version | 20230707 |
| Status | active |
| Date | 2023-07-07T01:01:08-04:00 |
| Name | TrastuzumabAndBiosimilars |
| Title | Trastuzumab and Biosimilars |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.) |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.1444.3.101",
"meta" : {
"versionId" : "14",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "American Society of Clinical Oncology Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-12-05"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2023-07-07"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.1444.3.101"
}
],
"version" : "20230707",
"name" : "TrastuzumabAndBiosimilars",
"title" : "Trastuzumab and Biosimilars",
"status" : "active",
"date" : "2023-07-07T01:01:08-04:00",
"publisher" : "American Society of Clinical Oncology Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1658084",
"display" : "ado-trastuzumab emtansine 100 MG Injection"
},
{
"code" : "1658089",
"display" : "ado-trastuzumab emtansine 160 MG Injection"
},
{
"code" : "1922509",
"display" : "trastuzumab 150 MG Injection"
},
{
"code" : "1922516",
"display" : "trastuzumab 21 MG/ML Injectable Solution"
},
{
"code" : "2107053",
"display" : "trastuzumab-pkrb 21 MG/ML Injectable Solution"
},
{
"code" : "2119714",
"display" : "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
},
{
"code" : "2169359",
"display" : "trastuzumab-pkrb 150 MG Injection"
},
{
"code" : "2174804",
"display" : "trastuzumab-anns 21 MG/ML Injectable Solution"
},
{
"code" : "2179753",
"display" : "trastuzumab-dkst 150 MG Injection"
},
{
"code" : "2179760",
"display" : "trastuzumab-dkst 21 MG/ML Injectable Solution"
},
{
"code" : "2257297",
"display" : "trastuzumab-anns 150 MG Injection"
},
{
"code" : "2267576",
"display" : "fam-trastuzumab deruxtecan-nxki 100 MG Injection"
},
{
"code" : "2280732",
"display" : "trastuzumab-qyyp 21 MG/ML Injectable Solution"
},
{
"code" : "2289227",
"display" : "trastuzumab-dttb 150 MG Injection"
},
{
"code" : "2289234",
"display" : "trastuzumab-dttb 21 MG/ML Injectable Solution"
},
{
"code" : "2382604",
"display" : "15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection"
},
{
"code" : "2383305",
"display" : "10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection"
},
{
"code" : "2472791",
"display" : "trastuzumab-qyyp 150 MG Injection"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:3ae67bbf-bcc4-45b9-a292-e06ce8bfa740",
"timestamp" : "2024-12-10T10:07:10-05:00",
"total" : 18,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1658084",
"display" : "ado-trastuzumab emtansine 100 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1658089",
"display" : "ado-trastuzumab emtansine 160 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1922509",
"display" : "trastuzumab 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1922516",
"display" : "trastuzumab 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2107053",
"display" : "trastuzumab-pkrb 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2119714",
"display" : "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2169359",
"display" : "trastuzumab-pkrb 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2174804",
"display" : "trastuzumab-anns 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2179753",
"display" : "trastuzumab-dkst 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2179760",
"display" : "trastuzumab-dkst 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2257297",
"display" : "trastuzumab-anns 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2267576",
"display" : "fam-trastuzumab deruxtecan-nxki 100 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2280732",
"display" : "trastuzumab-qyyp 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2289227",
"display" : "trastuzumab-dttb 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2289234",
"display" : "trastuzumab-dttb 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2382604",
"display" : "15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2383305",
"display" : "10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2472791",
"display" : "trastuzumab-qyyp 150 MG Injection"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.
FHIR